Chris Van Metre to step down as ATI CEO. Board unanimously appoints John Jansen as successor.
Advanced Technology International (ATI) today announced that Chris Van Metre will step down as Chief Executive Officer (CEO) and that the Board of Directors has unanimously appointed John Jansen as CEO and a member of the Board, effective July 2024.
Advanced Technology International wins Business of the Year award
The Charleston Metro Chamber has announced Advanced Technology International as the recipient of the Business of the Year award, one of seven Honors awards presented by the Chamber.
Advanced Technology International to manage Defense Industrial Base Consortium OT Agreement
Advanced Technology International (ATI) has been awarded an Other Transaction (OT) Agreement by the Department of Defense to establish and manage the Defense Industrial Base Consortium (DIBC).
Naval Surface Technology & Innovation Consortium reaches 1,000 members & $1 billion
The Naval Surface Technology & Innovation Consortium (NSTIC) today announces it has grown to over 1,000 members since its inception in 2019.
Advanced Technology International selected to manage new BARDA Biopharmaceutical Manufacturing Preparedness Consortium
Advanced Technology International (ATI) has been awarded an Other Transaction (OT) Agreement by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness (ASPR) and Response within the U.S. Department of Health and Human Services, to serve as the consortium manager for the new 10-year Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium).
Advanced Technology International signs Partnership Intermediary Agreement with Naval Surface Warfare Center – Indian Head Division
Advanced Technology International (ATI), a catalyst for research and development innovation, has entered into its first Partnership Intermediary Agreement (PIA) with Naval Surface Warfare Center Indian Head Division (NSWC IHD).
MTEC member SurgiBox Inc.’s product recognized as a best invention by Time Magazine
MTEC member and small business SurgiBox Inc. is an inventor of surgical kits that allow doctors to perform life-saving surgeries anywhere – even in the middle of war zones or other hostile situations.
Advanced Technology International to manage Expeditionary Missions Consortium – Crane OTA
Advanced Technology International (ATI) has been awarded an Other Transaction Agreement (OTA) by the Naval Surface Warfare Center, Crane Division (NSWC Crane) to serve as the consortium manager for the Expeditionary Missions Consortium - Crane.
National Science Foundation’s National Center for Science and Engineering Statistics funds over $7.5 million in National Secure Data Service demonstration projectsNational Science Foundation’s National Center for Science and Engineering Statistics funds over $7.5 million in National Secure Data Service demonstration projects
National Science Foundation’s National Center for Science and Engineering Statistics funds over $7.5 million in National Secure Data Service demonstration projects
NCSES is utilizing the America's DataHub Consortium (ADC) to award NSDS-D pilot projects. After a competitive project evaluation process, a variety of organizations were chosen, including three (3) non-traditional organizations, ones that do not typically work with NSF or NCSES.
ATI in the News
Undersea Technology Innovation Consortium members awarded $600 million in prototype project funding
Since UTIC’s inception in 2018, $600 million in prototype project funding has been awarded to members.
DOD launches distributed bioindustrial manufacturing program to bolster domestic supply chains
The DBMIP will execute investments through the Defense Industrial Base Consortium (DIBC) Other Transaction Agreement (OTA), which helps lower barriers to allow DoD to work more expeditiously with small, non-traditional, and large businesses.
Inhalon Biopharma secures U.S. Army Medical Research and Development Command award to support development of inhaled therapeutics for treatment of COVID-19
Inhalon Biopharma, a clinical-stage company advancing a proprietary inhaled antibody platform for treating acute respiratory infections (ARI), today announced that it has been awarded a $5.7 million contract by the U.S Army Medical Research and Development Command (USAMRDC) to support a U.S. Army Military Performance Advancement Initiative (MPAI) project to develop new treatments for COVID-19 and other SARS infections.